Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David L. Brinkley currently holds 18,000 shares of ARATANA THERAPEUTICS, INC. (PETX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David L. Brinkley has been a net seller of PETX stock. They have purchased $0 and sold $11.5M worth of shares.
David L. Brinkley's most recent insider trade was on Jul 18, 2019, when they sold 18,000 shares at $0.00 per share.
David L. Brinkley serves as Executive at ARATANA THERAPEUTICS, INC. (PETX). They have executed 113 insider transactions totaling $11.5M over their tenure at the company.
David L. Brinkley holds the position of Executive at ARATANA THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
David L. Brinkley has shown a selling trading pattern, with $0 in total purchases and $11.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David L. Brinkley was on Aug 3, 2012, when they sold $3.5M worth of THRX shares. This transaction involved 123,917 shares at $27.92 per share.
David L. Brinkley currently owns 18,000 shares of ARATANA THERAPEUTICS, INC. (PETX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David L. Brinkley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David L. Brinkley has 113 Form 4 filings on record as an insider at ARATANA THERAPEUTICS, INC..
Set alerts for David L. Brinkley and 40,000+ other insiders.